Breast Cancer Clinical Trial
Study of BMS-754807 Combined With Letrozole or BMS-754807 Alone in Patients With Hormone Receptor-Positive Breast Cancer and Resistance to Non-Steroidal Aromatase Inhibitors
Summary
The purpose of this study is to evaluate oral doses of BMS-754807 in combination with letrozole or BMS-754807 alone are safe and efficacious in locally advanced or metastatic hormone receptor positive breast cancer subjects who have progressed with prior non-steroidal aromatase inhibitor treatment.
Eligibility Criteria
For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com.
Inclusion Criteria:
Postmenopausal women with hormone receptor-positive and HER-2 negative breast cancer
Disease progression following non-steroidal aromatase inhibitor treatment
Exclusion Criteria:
Known symptomatic brain metastasis
Medical condition requiring chronic steroids
History of Type 1 or 2 Diabetes
Uncontrolled or significant cardiovascular (CV) disease
Concomitant second malignancies
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 17 Locations for this study
Birmingham Alabama, 35294, United States
Scottsdale Arizona, 85259, United States
San Diego California, 92123, United States
Jacksonville Florida, 32224, United States
Chicago Illinois, 60637, United States
Peoria Illinois, 61615, United States
Goshen Indiana, 46526, United States
Baltimore Maryland, 21231, United States
Baltimore Maryland, 21231, United States
Wheaton Maryland, 20902, United States
Minneapolis Minnesota, 55455, United States
Rochester Minnesota, 55905, United States
Chapel Hill North Carolina, 27599, United States
Chapel Hill North Carolina, 27599, United States
Charlotte North Carolina, 28204, United States
Durham North Carolina, 27710, United States
Houston Texas, 77030, United States
Houston Texas, 77030, United States
Charlottesville Virginia, 22908, United States
Madison Wisconsin, 53792, United States
Madison Wisconsin, 53792, United States
How clear is this clinincal trial information?

Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.